Digital ulcers in patients with systemic sclerosis

Autoimmun Rev. 2006 Feb;5(2):125-8. doi: 10.1016/j.autrev.2005.08.004. Epub 2005 Sep 13.

Abstract

Digital ulcers (DU), defined as necrotic lesions located at distal digits or overlying bony prominences, occur in up to 50% of patients with limited or diffuse systemic sclerosis (SSc). These lesions are extremely painful and lead to substantial functional disability. The pathogenesis of DU differs depending on their location. DU located at distal aspects of digits are thought to be related to tissue ischemia from several processes, including vasospasm secondary to Raynaud's phenomenon, intimal fibro-proliferation, and thrombosis of digital arteries. DU located over bony prominences, such as the phalangeal joints and elbows, are thought to be due to repetitive microtrauma and difficulty healing due to atrophic, avascular tissue overlying the joints. Management of DU include non-pharmacologic and pharmacologic modalities. This review summarizes the current available and investigational therapies for the treatment and prevention of DU in patients with SSc.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anticoagulants / therapeutic use
  • Epoprostenol / analogs & derivatives
  • Epoprostenol / therapeutic use
  • Fingers / pathology*
  • Humans
  • Piperazines / therapeutic use
  • Platelet Aggregation Inhibitors / therapeutic use
  • Purines
  • Scleroderma, Systemic / complications*
  • Serotonin Uptake Inhibitors / therapeutic use
  • Sildenafil Citrate
  • Skin Ulcer / etiology
  • Skin Ulcer / prevention & control*
  • Skin Ulcer / therapy
  • Sulfones
  • Therapies, Investigational
  • Vasodilator Agents / therapeutic use

Substances

  • Anticoagulants
  • Piperazines
  • Platelet Aggregation Inhibitors
  • Purines
  • Serotonin Uptake Inhibitors
  • Sulfones
  • Vasodilator Agents
  • Sildenafil Citrate
  • Epoprostenol
  • treprostinil